Spectrum Pharmaceuticals Inc. (SPPI)

7.76
NASDAQ : Health Technology
Prev Close 8.12
Day Low/High 7.71 / 8.17
52 Wk Low/High 6.22 / 25.29
Avg Volume 736.70K
Exchange NASDAQ
Shares Outstanding 104.06M
Market Cap 844.93M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Spectrum Pharmaceuticals, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of November 21, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Spectrum Pharmaceuticals, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of November 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Spectrum Pharmaceuticals, Inc.

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces a class action lawsuit against Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals Provides Third Quarter Financial Update

Spectrum Pharmaceuticals Provides Third Quarter Financial Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology announced today financial results for...

SPPI SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Shareholders Of A Class Action Involving Spectrum Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 21, 2016

SPPI SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Shareholders Of A Class Action Involving Spectrum Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of November 21, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Nevada on behalf of investors who purchased Spectrum Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces a class action lawsuit against Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals Provides Third Quarter Financial And Pipeline Update

Spectrum Pharmaceuticals Provides Third Quarter Financial And Pipeline Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology announced that the earnings...

GPM Reminds Investors Of The November 21st Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm

GPM Reminds Investors Of The November 21st Deadline In The Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") reminds investors of the November 21, 2016 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of investors who purchased or otherwise...

Tax-Loss Selling Offers Stock-Picking Opportunities

Our screen reveals 17 names that could become oversold and disconnected from their fundamentals as a result of this phenomenon.

Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a...

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Spectrum Pharmaceuticals, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Spectrum Pharmaceuticals, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals Announces Appointment Of Luigi Lenaz, M.D., As Lead Director

Spectrum Pharmaceuticals Announces Appointment Of Luigi Lenaz, M.D., As Lead Director

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that independent director...

Spectrum Pharmaceuticals Becomes Oversold (SPPI)

Spectrum Pharmaceuticals Becomes Oversold (SPPI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SPPI LOSS NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action Filed By Firm - SPPI

SPPI LOSS NOTICE: Rosen Law Firm Reminds Spectrum Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action Filed By Firm - SPPI

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Spectrum Pharmaceuticals, Inc.

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Spectrum Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Against Spectrum Pharmaceuticals, Inc. - SPPI

Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Spectrum Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Spectrum Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Spectrum Pharmaceuticals, Inc.

Levi & Korsinsky, LLP announces that it has commenced an investigation of Spectrum Pharmaceuticals, Inc.

First Week of SPPI May 2017 Options Trading

First Week of SPPI May 2017 Options Trading

Investors in Spectrum Pharmaceuticals Inc saw new options become available this week, for the May 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Spectrum Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Spectrum Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Spectrum Pharmaceuticals, Inc.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces An Investigation Of Spectrum Pharmaceuticals, Inc. And Advises Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces An Investigation Of Spectrum Pharmaceuticals, Inc. And Advises Investors With Losses To Contact The Firm

Lundin Law PC ( http://lundinlawpc.com/) announces that it is investigating claims against Spectrum Pharmaceuticals, Inc.

Spectrum Pharma, FDA and the Buried Truth About a Bladder Cancer Drug Meeting

Spectrum Pharma, FDA and the Buried Truth About a Bladder Cancer Drug Meeting

The FDA told Spectrum not to seek approval for its bladder cancer drug. Spectrum filed anyway but never told investors about the FDA warning.

Spectrum Pharmaceuticals (SPPI) Stock Slumps on FDA Ruling

Spectrum Pharmaceuticals (SPPI) Stock Slumps on FDA Ruling

An FDA committee said on Wednesday that Spectrum Pharmaceuticals' (SPPI) Qapzola drug for bladder tumors did not show substantial evidence of efficacy.

FDA Advisory Committee Votes That Qapzola™ (apaziquone) Has Not Shown Substantial Evidence Of A Treatment Effect Over Placebo

FDA Advisory Committee Votes That Qapzola™ (apaziquone) Has Not Shown Substantial Evidence Of A Treatment Effect Over Placebo

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.

Spectrum Pharmaceuticals Stock Sees Short Interest Decline 15%

Spectrum Pharmaceuticals Stock Sees Short Interest Decline 15%

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 1,258,512 share decrease in total short interest for Spectrum Pharmaceuticals Inc , to 7,187,253, a decrease of 14.90% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

October 21st Options Now Available For Spectrum Pharmaceuticals (SPPI)

October 21st Options Now Available For Spectrum Pharmaceuticals (SPPI)

Investors in Spectrum Pharmaceuticals Inc saw new options become available today, for the October 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SPPI options chain for the new October 21st contracts and identified the following put contract of particular interest.

RSI Alert: Spectrum Pharmaceuticals (SPPI) Now Oversold

RSI Alert: Spectrum Pharmaceuticals (SPPI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results And Pipeline Update

Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results And Pipeline Update

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today financial results...

Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference And Webcast

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a...

Spectrum Pharmaceuticals Becomes Oversold (SPPI)

Spectrum Pharmaceuticals Becomes Oversold (SPPI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate Injection) ANDA Patent Litigation

Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate Injection) ANDA Patent Litigation

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that it has settled its...

TheStreet Quant Rating: D (Sell)